特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
970264

従来型および代替的疼痛治療の世界市場

Conventional and Alternative Pain Treatment Markets

出版日: | 発行: BCC Research | ページ情報: 英文 260 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
従来型および代替的疼痛治療の世界市場
出版日: 2020年11月09日
発行: BCC Research
ページ情報: 英文 260 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の従来型および代替的疼痛治療の市場規模は予測期間中6.3%のCAGRで推移し、2020年の761億米ドルから、2025年には1033億米ドルの規模に成長すると予測されています。製品区分別では、疼痛治療薬の部門が同期間中6.4%で推移し、719億米ドルから、982億米ドルの規模に成長する見通しです。また、デバイス部門は同期間中3.8%のCAGRで推移し、43億米ドルから、51億米ドルの規模に成長する見通しです。

当レポートでは、世界の疼痛管理の市場を調査し、市場の定義と概要、診断・治療の種類と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、医薬品・デバイスタイプ・地域など各種区分別の内訳、特許動向、産業における新たな展開、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 産業概要

  • 市場機会
  • 疼痛治療:総市場
  • 疼痛・疼痛治療の発展の経緯
  • 疼痛のタイプ
  • 疼痛の診断
  • 疼痛の治療法
  • ドラッグデリバリーシステム
  • 疼痛管理の代替方法
  • 医療大麻の採用:世界の分析
  • 疼痛管理サービス・組織
  • 市場影響因子・成長指標、など

第4章 市場分析・予測:医薬品&デバイスタイプ別

  • 概要
  • 市場の概要
  • 薬による疼痛管理
  • 疼痛管理製品
  • アセトアミノフェン・FDAによる変更
  • 咳止め薬・風邪薬におけるコデイン
  • 総市場
  • 疼痛治療のFDA承認
  • 医薬品パイプライン
  • 麻薬性鎮痛薬
  • 非麻薬性鎮痛薬
  • 医療大麻
  • 抗片頭痛剤
  • 麻酔薬
  • その他の中枢神経系治療薬
  • その他の治療薬
  • 疼痛管理デバイス
  • 疼痛デバイスのFDA承認
  • 疼痛管理デバイス市場
  • 総市場
  • 刺激療法
  • 身体的疼痛治療モダリティ
  • 鍼治療/指圧
  • 氷(凍結療法)
  • 関節モビリゼーション
  • 手技
  • マッサージ
  • 牽引
  • 放射線治療
  • 高周波神経切除、エピデュロスコピー
  • 手術
  • ジェットバス(温熱療法)
  • 心理的疼痛治療
  • 補完的・代替的疼痛管理

第5章 市場分析・予測:用途別

  • 概要
  • 市場規模・成長
  • 外科的疼痛管理
  • 整形外科/筋骨格
  • 片頭痛
  • 線維筋痛症
  • 癌性疼痛管理
  • 神経因性疼痛
  • HIV / AIDS
  • 火傷
  • 歯痛

第6章 市場分析・予測:地域別

  • 概要
  • 市場規模・成長
  • 世界の医療指標
  • 医療費・GDPのレビュー
  • 北米
  • カナダ
  • 米国
  • 欧州・中東・アフリカ
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • スペイン
  • 英国
  • アジア太平洋
  • オーストラリア
  • 中国
  • 日本
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ

第7章 特許分析・新たな展開

第8章 企業プロファイル

  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • AMGEN INC.
  • APHRIA INC.
  • ASSERTIO THERAPEUTICS
  • AURORA CANNABIS INC.
  • BAXTER INTERNATIONAL
  • BEDROCAN INTERNATIONAL
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BOSTON SCIENTIFIC CORP.
  • COLLEGIUM PHARMACEUTICALS INC.
  • CANOPY GROWTH CORP.
  • CRONOS GROUP INC.
  • DR. REDDY'S LABORATORIES LTD.
  • ELI LILLY & CO.
  • ENDO INTERNATIONAL PLC
  • FRESENIUS KABI AG
  • GLAXOSMITHKLINE
  • GRUNENTHAL GMBH
  • GW PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HORIZON THERAPEUTICS PLC
  • JOHNSON & JOHNSON
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • MEDTRONIC PLC
  • MERCK & CO. LTD.
  • NOVARTIS AG
  • PFIZER INC.
  • PURDUE PHARMA LP
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

第9章 付録:用語・情報源

図表

List of Tables

  • Summary Table : Global Market for Conventional and Alternative Pain Treatments, by Major Segment, Through 2025
  • Table 1 : Market Opportunities and Highlights for Pain Treatments, 2020-2025
  • Table 2 : Physiological Effects of Pain
  • Table 3 : Objective Signs of Pain
  • Table 4 : United States Opioid Addiction and Abuse Statistics
  • Table 5 : Global Opioid Addiction and Abuse Statistics
  • Table 6 : List of Brand Name Extended-Release and Long-Acting Opioid Products Required to be Included in Opioid REMS
  • Table 7 : List of Generic Extended-Release and Long-Acting Opioid Products Required to be Included in Opioid REMS
  • Table 8 : List of Transmucosal Immediate-Release Fentanyl Products Required to be Included in the TIRF REMS Access Program
  • Table 9 : List of Other Pain-Related REMS-Required Products
  • Table 10 : List of Products Subject to the TIRF REMS Access Program
  • Table 11 : Advantages of Iontophoretic Drug Delivery
  • Table 12 : Adoption of Medical Cannabis in Population Aged 15 Years and Above, by Select Country, 2020
  • Table 13 : U.S. Medical Marijuana/Cannabis Programs, by State
  • Table 14 : European Medical Marijuana/Cannabis Regulation, by Country
  • Table 15 : Select Country Medical Marijuana/Cannabis Regulation
  • Table 16 : Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies, 2014
  • Table 17 : Shares of the U.S. Hospice Patients, by Gender and Age Group, 2010-2018
  • Table 18 : Hospice Admissions Shares, by Primary Diagnosis, 2016-2018
  • Table 19 : NHPCO Committees
  • Table 20 : Definition of Pain Clinics
  • Table 21 : Desirable Characteristics of Pain Clinics, by Type
  • Table 22 : Registered Pain Clinics, by Country
  • Table 23 : Global Population Growth, by Select Country, Through 2030
  • Table 24 : Global Population Growth, by Age Group, Through 2050
  • Table 25 : Global Population Growth, Aged 65+ Years and Above, by Select Country, Through 2030
  • Table 26 : Global Life Expectancy at Birth, by Select Country, 2020 Estimate
  • Table 27 : Pain in the Age 18+ U.S. Population*, by Select Gender, 1997-2010
  • Table 28 : Agency Responsible for PDMP in Each State
  • Table 29 : Benefits of Prescription Monitoring Programs for Medical Boards
  • Table 30 : Drugs Monitored by PDMPs, by State
  • Table 31 : WHO List of Essential Medicines for Adult Pain Management
  • Table 32 : Availability of Injectable Morphine, by Region
  • Table 33 : Availability of Oral Morphine in Hospice-Type Settings, by Region
  • Table 34 : FDA Reported Pain and Anesthesia Drug Shortages, by Status and Drug, January 2020-September 2020
  • Table 35 : Global Market for Pain Management, by Major Type, Through 2025
  • Table 36 : Share of Pharmaceutical Pain Management Treatment Markets, by General Classification, 2020
  • Table 37 : FDA Applications/Approvals, January 2010-August 2020
  • Table 38 : List of Prescription Cough and Cold Medicines Containing Codeine
  • Table 39 : List of Prescription Cough and Cold Medicines Containing Hydrocodone
  • Table 40 : Global Market for Pain Management Pharmaceuticals, by Product Category, Through 2025
  • Table 41 : Select Pain Management Drugs in Pipelines, by Company
  • Table 42 : Pediatric Pain Management Indications Select Pipeline, by Company
  • Table 43 : Selected Approved ER/LA Opioids with Abuse Deterrent Properties
  • Table 44 : List of NSAIDs
  • Table 45 : Selected Cannabis Clinical Trials for Pain Treatment, as of September 15, 2020
  • Table 46 : Most Commonly Used General Anesthetic Agents
  • Table 47 : Global Market for Allergan's Botox, by Treatment Area, 2020 (based on 6M Sales)
  • Table 48 : Parts 862-892 of 21 CFR
  • Table 49 : Global Market for Pain Management Devices, by Technology Type, Through 2025
  • Table 50 : Use of Complementary and Alternative Medicine among U.S. Adults, by Type of Therapy, 2002-2018
  • Table 51 : Global Market for Pain Management, by Application, Through 2025
  • Table 52 : Global Market for Surgical Pain Management, by Product Type, Through 2025
  • Table 53 : Annual No. of Operations, by Country (Estimated)
  • Table 54 : Birth Rates and Births, by Select Country, 2020 and 2025
  • Table 55 : Global Market for Orthopedic/Musculoskeletal Pain Management, by Product Type, Through 2025
  • Table 56 : Global Market for Migraine/Headache Pain Management, by Product Type, Through 2025
  • Table 57 : Global Market for Fibromyalgia Pain Management, by Product Type, Through 2025
  • Table 58 : Cancer Pain Medication
  • Table 59 : Global Market for Cancer Pain Management, by Product Type, Through 2025
  • Table 60 : Global Market for Neuropathic Pain Management, by Product Type, Through 2025
  • Table 61 : Global Market for HIV/AIDS Pain Management, by Product Type, Through 2025
  • Table 62 : Global Market for Burn Pain Management, by Product Type, Through 2025
  • Table 63 : Global Market for Dental Pain Management, Through 2025
  • Table 64 : Global Market for Pain Management, by Region, Through 2025
  • Table 65 : Health Expenditures as a Percentage of GDP, by Select Country, 1980-2019
  • Table 66 : Average Hospital Length of Stay, by Select Country, 1970-2019
  • Table 67 : Major Countries, by Region
  • Table 68 : North American Market for Pain Management, by Type, Through 2025
  • Table 69 : North American Market for Pain Treatment, by Country, Through 2025
  • Table 70 : EMEA Market for Pain Management, by Type, Through 2025
  • Table 71 : EMEA Market for Pain Treatment, by Country, Through 2025
  • Table 72 : Asia-Pacific Market for Pain Management, by Type, Through 2025
  • Table 73 : Asia-Pacific Market for Pain Treatment, by Country, Through 2025
  • Table 74 : Latin American Market for Pain Management, by Type, Through 2025
  • Table 75 : Latin American Market for Pain Treatment, by Country, Through 2025
  • Table 76 : U.S. Patents Issued on Pain Treatments, by Year, January 2000-August 2020
  • Table 77 : U.S. Patents Issued on Pain Technologies, by Abstract Description, January 2000-August 2020
  • Table 78 : Recent Country Patents on Pain Technologies, August 18, 2020-September 22, 2020
  • Table 79 : First Time Prescription Generic Pain Management and Approvals, January 2010-August 2020
  • Table 80 : Glossary of terms used in Pain Management Drug and Device Markets
  • Table 81 : Pain Management Therapy Manufacturers and Developers
  • Table 82 : U.S. Pain Societies and Associations
  • Table 83 : International Associations and Organizations

List of Figures

  • Summary Figure : Global Market for Conventional and Alternative Pain Treatments, by Major Segment, 2019-2025
  • Figure 1 : Global Market for Conventional and Alternative Pain Treatments, 2019-2025
  • Figure 2 : Pain Management Techniques
  • Figure 3 : Annual Number of U.S. Hospice Patients, 2010-2018
  • Figure 4 : U.S. Shares of Hospice Patients, by Gender, 2010-2018
  • Figure 5 : U.S. Shares of Hospice Patients, by Age Group, 2010-2018
  • Figure 6 : Distribution of Causes of Mortality and Potential need for Palliative Care, 2017*
  • Figure 7 : Global Population Growth, by Select Country, 2019 and 2030
  • Figure 8 : Global Population Growth, by Age Group, 2000-2050
  • Figure 9 : Global Population Growth, Aged 65+ Years and Above, by Select Country, 2019 and 2030
  • Figure 10 : Global Life Expectancy at Birth, by Select Country, 2020 Estimate
  • Figure 11 : Pain in the Age 18+ U.S. Population*, by Select Gender, 1997-2010
  • Figure 12 : Distribution of Narcotic Drug Consumption, by Country (All Narcotic Types), 2015
  • Figure 13 : Distribution of Morphine Consumption, by Region/Country, 2015
  • Figure 14 : Obstacles to Availability of Opioids for Medical Needs
  • Figure 15 : Global Market for Pain Management, by Major Type, 2019-2025
  • Figure 16 : Global Market for Pain Management Pharmaceuticals, by Product Category, 2019-2025
  • Figure 17 : Shares of Pain Management Drugs in Pipeline, by Development Status
  • Figure 18 : Shares of Pain Management Drugs in Pipeline, by Primary Indication
  • Figure 19 : Global Market Shares of Narcotic Pain Treatments, by Indication, 2020
  • Figure 20 : Global Market Shares of Narcotic Analgesics, by Ingredient*, 2020
  • Figure 21 : Market Shares Distribution: Non-Narcotic Analgesics, Rx vs. OTC, 2020
  • Figure 22 : Global Market Shares of Non-Narcotic Pain Treatments, by Indication, 2020
  • Figure 23 : Global Market Shares of Non-Narcotic Analgesics, by Ingredient*, 2020
  • Figure 24 : Global Market Shares of Medical Cannabis: Pain vs. All Other Uses, 2020
  • Figure 25 : Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2020
  • Figure 26 : Global Market Shares of Antimigraine Agents, by Classification, 2020
  • Figure 27 : Global Market Shares of Antimigraine Agents, by Ingredient*, 2020
  • Figure 28 : Global Market Shares of Anesthetics, by Ingredient*, 2020
  • Figure 29 : Global Market Shares of CNS Pain Treatments, by Indication, 2020
  • Figure 30 : Global Market Shares of Capsaicin-Derived Pain Treatments, by Indication, 2020
  • Figure 31 : Global Market Shares of Menthol-Containing Pain Treatments, by Indication, 2020
  • Figure 32 : Global Market Shares of Omega-3 Fatty Acid-Containing Pain Treatments, by Indication, 2020
  • Figure 33 : Global Market Shares of Botulinum Toxin Pain Treatments, by Indication, 2020
  • Figure 34 : Global Market for Pain Management Devices, by Technology Type, 2019-2025
  • Figure 35 : Use of Complementary and Alternative Medicine among U.S. Adults, by Type of Therapy, 2002-2018
  • Figure 36 : Global Market for Pain Management, by Application, 2019-2025
  • Figure 37 : Global Market for Surgical Pain Management, by Product Type, 2019-2025
  • Figure 38 : Birth Rates and Births, by Select Country, 2020 and 2025
  • Figure 39 : Arthritis Impact, Global Prevalence, by Year, 2000-2050
  • Figure 40 : Global Cancer Mortality, by Select Country, 1960-2020 (Estimated)
  • Figure 41 : Causes of Cancer Pain
  • Figure 42 : Burn Pain Management Approach
  • Figure 43 : Global Market for Pain Management, by Region, 2019-2025
  • Figure 44 : Health Expenditures as a Percentage of GDP, by Select Country, 1980-2019
  • Figure 45 : North American Market for Pain Treatment, by Country, 2019-2025
  • Figure 46 : North American Market Shares of Pain Treatment, by Country, 2020
  • Figure 47 : Canadian Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 48 : Canadian Market Shares of Pain Treatments, by Application, 2020
  • Figure 49 : U.S. Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 50 : U.S. Market Shares of Pain Treatments, by Application, 2020
  • Figure 51 : EMEA Market for Non-opioid Pain Treatment, by Country, 2019-2025
  • Figure 52 : EMEA Market Shares of Pain Treatments, by Country, 2020
  • Figure 53 : French Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 54 : French Market Shares of Pain Treatments, by Application, 2020
  • Figure 55 : German Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 56 : German Market Shares of Pain Treatments, by Application, 2020
  • Figure 57 : Italian Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 58 : Italian Market Shares of Pain Treatments, by Application, 2020
  • Figure 59 : Russian Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 60 : Russian Market Shares of Pain Treatments, by Application, 2020
  • Figure 61 : Spanish Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 62 : Spanish Market Shares of Pain Treatments, by Application, 2020
  • Figure 63 : U.K. Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 64 : U.K. Market Shares of Pain Treatments, by Application, 2020
  • Figure 65 : Asia-Pacific Market for Pain Treatment, by Country, 2019-2025
  • Figure 66 : Asia-Pacific Market Shares of Pain Treatments, by Country, 2020
  • Figure 67 : Australian Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 68 : Australian Market Shares of Pain Treatments, by Application, 2020
  • Figure 69 : Chinese Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 70 : Chinese Market Shares of Pain Treatments, by Application, 2020
  • Figure 71 : Japanese Market Shares of Pain Treatments, by Product Segment, 2020
  • Figure 72 : Japanese Market Shares of Pain Treatments, by Application, 2020
  • Figure 73 : Latin American Market for Pain Treatment, by Country, 2019-2025
  • Figure 74 : Latin American Market Shares of Pain Treatment, by Country, 2020
  • Figure 75 : Argentinean Market Shares of Pain Treatment, by Product Segment, 2020
  • Figure 76 : Argentinean Market Shares of Pain Treatment, by Application, 2020
  • Figure 77 : Brazilian Market Shares of Pain Treatment, by Product Segment, 2020
  • Figure 78 : Brazilian Market Shares of Pain Treatment, by Application, 2020
  • Figure 79 : Mexican Market Shares of Pain Treatment, by Product Segment, 2020
  • Figure 80 : Mexican Market Shares of Pain Treatment, by Application, 2020
  • Figure 81 : U.S. Shares of Patents Issued on Pain Technologies, by Year, January 2000-August 2020
  • Figure 82 : U.S. Shares of Patents Issued on Pain Technologies, by Abstract Description
  • Figure 83 : Country Patent Shares of Pain Technologies
  • Figure 84 : FDA Generic Pain Drug Approvals, by Year, 2010-2020*
目次
Product Code: HLC266A

Highlights:

The global market for conventional and alternative pain treatments should grow from $76.1 billion in 2020 to $103.3 billion by 2025, at compound annual growth rate (CAGR) of 6.3% for the period of 2020-2025.

The pharmaceuticals, drug therapy segment market for conventional and alternative pain treatments should grow from $71.9 billion in 2020 to $98.2 billion by 2025, at a CAGR of 6.4% for the period of 2020-2025.

The devices segment market for conventional and alternative pain treatments should grow from $4.3 billion in 2020 to $5.1 billion by 2025, at a CAGR of 3.8% for the period of 2020-2025.

##img_0##

Report Scope:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies two general segments of pain management -

  • Pharmaceuticals, including prescription and non-prescription.

Narcotic analgesics.

Non-narcotic analgesics.

Medical cannabis.

Antimigraine agents.

Anesthesia.

CNS therapies.

Other treatments.

  • Devices.

Electrotherapy.

Spinal cord stimulator.

Other devices.

Adjuvant treatment modalities cover a wide range of procedures and methods. Some of the more frequent modalities are discussed throughout the report.

Each market segment provides detailed information based on product categories, product use and market forecasts.

Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.

A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include -

  • Enbrel: Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
  • Celebrex: Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

The report is also evaluated in terms of application, discussing market trends and performance for the following areas -

  • Surgical pain.
  • Orthopedic and musculoskeletal pain.
  • Migraine pain.
  • Fibromyalgia pain.
  • Cancer pain.
  • Neuropathic pain.
  • HIV/AIDS pain.
  • Dental pain.
  • General pain.

Report Includes:

  • 40 data tables and 43 additional tables
  • An overview of the global market for conventional and alternative pain treatments
  • Analyses of the global market trends, with data corresponding to market size for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Country-specific data and analysis for the United States, Canada, Brazil, Mexico, Argentina, France, Germany, Italy, UK, Spain, Russia, Australia, China, Japan, and other emerging economies
  • Patent study with significant patent allotments on pain treatments, application filings, and new drug approvals
  • Identification of companies best-positioned to meet the conventional and alternative pain management markets demand owing to their proprietary technologies, collaborations, M&As and other strategic alliances
  • Market share analysis of the leading biopharmaceutical companies and their key competitive landscape
  • Global market outlook of pain management services, types of pain, delivery methods, clinical trials, pain incidence/prevalence, reimbursement trends, R&D efforts, and treatment modalities
  • Detailed description of the market leading companies, including Abbott Laboratories, Baxter International, Eli Lilly & Co., GlaxoSmithKline, and Johnson & Johnson

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Overview
  • Summary of the Major Markets
  • Competitive Structure and Market Share
  • Market Trends
  • Undertreatment Issues
  • Professional Pain Treatment Issues
  • Access to Care
  • FDA Requirements for Approval of Pain Therapies
  • Drug Delivery Systems

Chapter 3 Industry Overview

  • Pain Management Market Opportunity
  • Total Pain Treatment Market
  • History of Pain and Pain Treatment
  • The Perception of Pain
  • Types of Pain
  • Acute Pain
  • Chronic Pain
  • Physiological Pain Classifications
  • Assessment of Pain
  • Subjective
  • Objective
  • Diagnosis of Pain
  • How Pain is Treated
  • Opioid Pain Control
  • The Opioid Crisis: Addiction and Abuse
  • FDA Response to the Opioid Crisis-Risk Evaluation and Mitigation Strategy (REMS)
  • Opioid Treatment Challenges
  • Drug Delivery Systems
  • Oral and Extended Release
  • Topical and Transdermal
  • Intravenous
  • Intranasal
  • Patient-Controlled Analgesia
  • Iontophoresis
  • Electromechanical Transport
  • Pain Management Procedures: Steroids, Endoscopy, Fluoroscopy
  • Alternative Methods of Pain Management
  • Growing Trend in Cannabis Treatment for Pain
  • Adoption of Medical Cannabis: A Global Analysis
  • Laws and Legalization Trends
  • Claims in Effectiveness
  • Potency and Validation Testing Trends
  • Pain Management Services and Organizations
  • Home Care
  • Hospice
  • Hospitals
  • Pain Clinics
  • Skilled Nursing Facilities
  • Access to Palliative Care Around the World
  • Assessing the Need for Palliative Care
  • Market Influences and Indicators of Growth
  • Global Demographic Overview
  • Gender and Pain
  • Other Influences Determining How Pain is Felt among Individuals
  • Undertreatment Issues
  • Treatment of Pain and Issues Facing the Professional Segment
  • Prescription Drug Monitoring Programs
  • Availability of Medication
  • Government Intervention
  • Managed Care Pain Management Issues

Chapter 4 Pain Treatment Markets by Type

  • Overview
  • Market Summary
  • Pharmaceutical Pain Management
  • Pain Management Products
  • Acetaminophen and FDA Changes
  • Codeine in Cough and Cold Medications
  • Total Market
  • FDA Approval of Pain Therapies
  • Pharmaceutical Pipeline
  • Narcotic Analgesics
  • Non-narcotic Analgesics
  • Medical Cannabis
  • Antimigraine Agents
  • Anesthetics
  • Other CNS Therapies
  • Other Treatments
  • Pain Management Devices
  • FDA Approval of Pain Devices
  • Pain Management Device Market
  • Total Market
  • Stimulation Therapy
  • Physical Pain Treatment Modalities
  • Acupuncture/Acupressure
  • Ice (Cryotherapy)
  • Joint Mobilization
  • Manipulation
  • Massage
  • Traction
  • Radiation Therapy
  • Radio Frequency Neuroablation, Epiduroscopy
  • Surgery
  • Whirlpool Bath (Thermotherapy)
  • Psychological Pain Therapies
  • Tracking the Development of Complementary and Alternative Pain Control Methods

Chapter 5 Market Breakdown by Application

  • Overview
  • Market Size and Growth
  • Surgical Pain Management
  • Orthopedic/Musculoskeletal Pain Management
  • Migraine Headache Pain Management
  • Fibromyalgia Pain
  • Cancer Pain Management
  • Neuropathic Pain
  • HIV/AIDS Related Pain
  • Burn Pain
  • Dental Pain

Chapter 6 Market Breakdown by Region

  • Overview
  • Market Size and Growth
  • Global Health Indicators
  • Health Expenditures and GDP Review
  • Average Length of Stay
  • Markets by Global Region
  • North America
  • Canada
  • United States
  • Europe, Middle East, Africa (EMEA)
  • France
  • Germany
  • Italy
  • Russia
  • Spain
  • United Kingdom
  • Asia-Pacific
  • Australia
  • China
  • Japan
  • Latin America
  • Argentina
  • Brazil
  • Mexico

Chapter 7 Patent Analysis and New Developments

  • Patent Analysis
  • Patent Review by Year
  • Patent Review by Type
  • Patent Review by Company
  • Patent Review by Country
  • Patent Review by Assignee
  • Impact of Generic Participation
  • Future of Pain Research
  • Selected Pain-Related Acquisitions, Alliances and Events

Chapter 8 Company Profiles

  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • AMGEN INC.
  • APHRIA INC.
  • ASSERTIO THERAPEUTICS
  • AURORA CANNABIS INC.
  • BAXTER INTERNATIONAL
  • BEDROCAN INTERNATIONAL
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BOSTON SCIENTIFIC CORP.
  • COLLEGIUM PHARMACEUTICALS INC.
  • CANOPY GROWTH CORP.
  • CRONOS GROUP INC.
  • DR. REDDY'S LABORATORIES LTD.
  • ELI LILLY & CO.
  • ENDO INTERNATIONAL PLC
  • FRESENIUS KABI AG
  • GLAXOSMITHKLINE
  • GRUNENTHAL GMBH
  • GW PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HORIZON THERAPEUTICS PLC
  • JOHNSON & JOHNSON
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • MEDTRONIC PLC
  • MERCK & CO. LTD.
  • NOVARTIS AG
  • PFIZER INC.
  • PURDUE PHARMA LP
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter 9 Appendix: Terminology and Sources of Information

  • Pain Management Pharmaceutical Manufacturers and Developers
  • U.S. Pain Societies and Associations
  • International Associations and Organizations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.